Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lung cancer screening.

Annette McWilliams1, Stephen Lam

  • 1British Columbia Cancer Agency, Vancouver, Canada.

Current Opinion in Pulmonary Medicine
|June 2, 2005
PubMed
Summary
This summary is machine-generated.

Lung cancer screening shows promise with advanced imaging and biomarkers. Identifying high-risk individuals with biomarkers can improve the effectiveness and reduce costs of lung cancer detection methods.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and transcriptomic characterization of mixed granulocytic COPD phenotype.

The Journal of allergy and clinical immunology·2026
Same author

Retargeted serine integrases for one-step, precise integration of large DNA sequences in human cells.

Nature biotechnology·2026
Same author

Fusion of Clinical and Deep Learning Features for Predicting Pembrolizumab Monotherapy Response in Advanced Non-Small Cell Lung Cancer.

Journal of clinical medicine·2026
Same author

Benchmarking of AI and Radiologists for Indeterminate Lung Nodule Malignancy Risk Estimation on Screening CT: The LUNA25 Challenge.

Radiology. Artificial intelligence·2026
Same author

Plasma signals of lung tumor promotion for molecular cancer prevention.

Cell·2026
Same author

Large-scale association study identifies lung cancer susceptibility copy number variants and their potential functional role in genetic instability.

medRxiv : the preprint server for health sciences·2026
Same journal

Nonsteroid treatment options in (pulmonary) sarcoidosis. When to consider and why?

Current opinion in pulmonary medicine·2026
Same journal

Multidisciplinary approach in cardiac sarcoidosis: to biopsy or not?

Current opinion in pulmonary medicine·2026
Same journal

Low diffusion capacity in pulmonary hypertension.

Current opinion in pulmonary medicine·2026
Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026
Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026
Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026
See all related articles

Area of Science:

  • Oncology
  • Medical Imaging
  • Biomarker Research

Background:

  • Lung cancer remains a leading cause of cancer mortality.
  • Previous screening efforts for other cancers have demonstrated success.
  • Advances in technology offer new possibilities for early lung cancer detection.

Purpose of the Study:

  • To review recent advances in lung cancer screening technologies.
  • To evaluate the potential of imaging and biomarkers in reducing lung cancer incidence and mortality.
  • To explore methods for improving the specificity and cost-effectiveness of lung cancer screening.

Main Methods:

  • Review of current imaging technologies like spiral computed tomography (CT) and autofluorescence bronchoscopy.
  • Analysis of biomarker research in sputum, blood, and exhaled breath for lung cancer detection.

Related Experiment Videos

  • Exploration of genetic susceptibility factors in lung cancer risk assessment.

    • Main Results:

    • Spiral CT and autofluorescence bronchoscopy offer high sensitivity for detecting preinvasive lung cancer.
    • These sensitive methods suffer from low specificity, leading to potential overdiagnosis and unnecessary procedures.
    • Biomarkers and genetic susceptibility information may enhance the positive predictive value of screening.

    Conclusions:

    • Biomarkers in sputum, blood, or breath show potential as an initial screening step.
    • Identifying high-risk individuals can optimize the use of advanced imaging like spiral CT.
    • Improved biomarker performance is key to selecting individuals who will benefit most from lung cancer screening.